28392427|t|Immune dysregulation in offspring of a bipolar parent. Altered serum levels of immune growth factors at adolescent age
28392427|a|Immune dysregulation plays a role in the vulnerability for mood disorders. Immune growth factors, such as Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein-2 (IGF-BP2), Epidermal Growth Factor (EGF), IL-7 and sCD25 have repeatedly been reported altered in patients with mood disorders. The aim of this study was to investigate levels of these factors in serum of adolescent bipolar offspring, who have a heightened risk for mood disorder development and to also analyze the data combined with previously published data. Growth factors were assessed by CBA / ELISA in adolescent bipolar offspring (n=96, mean age =16 years) and in age - and gender - matched healthy controls (n=50). EGF belonged to a mutually correlating cluster of mainly neurotrophic compounds including S100B and BDNF, which were in general decreased in serum. IL-7, SCF, IGF-BP2 and sCD25, belonged to a different mutually correlating cluster of immune growth factors, which were in general increased: IGF-BP2 significantly in serum of offspring without a mood disorder, IL-7 and SCF in serum of offspring who had expirienced a mood episode. This pattern of de - and increases was not different between bipolar offspring that developed or did not develop a mood disorder over time, apart from the IGF-BP2 level, which was near significantly higher in offspring later developing a mood disorder. Correlations with the previously published immune-cellular abnormalities were not found. In conclusion non-affected adolescents at familial mood disorder development risk were characterized by a distinct pattern of a series of compounds operating in a network of hematopoiesis, neurogenesis and inflammation.
28392427	0	20	Immune dysregulation	T033	C1844666
28392427	24	33	offspring	T099	C0680063
28392427	39	46	bipolar	T048	C0005586
28392427	47	53	parent	T099	C0030551
28392427	63	68	serum	T031	C0229671
28392427	69	75	levels	T080	C0441889
28392427	79	85	immune	T169	C0439662
28392427	86	100	growth factors	T116,T123	C0018284
28392427	104	118	adolescent age	T100	C0205653
28392427	119	139	Immune dysregulation	T033	C1844666
28392427	160	173	vulnerability	T033	C1821973
28392427	178	192	mood disorders	T048	C0525045
28392427	194	200	Immune	T169	C0439662
28392427	201	215	growth factors	T116,T123	C0018284
28392427	225	241	Stem Cell Factor	T116,T123	C0143630
28392427	243	246	SCF	T116,T123	C0143630
28392427	249	293	Insulin-like Growth Factor-Binding Protein-2	T116,T123	C0123257
28392427	295	302	IGF-BP2	T116,T123	C0123257
28392427	305	328	Epidermal Growth Factor	T116,T121,T125	C0242275
28392427	330	333	EGF	T116,T121,T125	C0242275
28392427	336	340	IL-7	T116,T121,T129	C0021761
28392427	345	350	sCD25	T116,T129,T192	C0487019
28392427	381	388	altered	T169	C0392747
28392427	392	400	patients	T101	C0030705
28392427	406	420	mood disorders	T048	C0525045
28392427	438	443	study	T062	C2603343
28392427	451	462	investigate	T169	C1292732
28392427	463	469	levels	T080	C0441889
28392427	479	486	factors	T116,T123	C0018284
28392427	490	495	serum	T031	C0229671
28392427	499	509	adolescent	T100	C0205653
28392427	510	517	bipolar	T048	C0005586
28392427	518	527	offspring	T099	C0680063
28392427	540	550	heightened	T080	C0442803
28392427	551	555	risk	T078	C0035647
28392427	560	573	mood disorder	T048	C0525045
28392427	574	585	development	T169	C1527148
28392427	598	605	analyze	T062	C0936012
28392427	610	614	data	T078	C1511726
28392427	640	654	published data	T170	C1704324
28392427	656	670	Growth factors	T116,T123	C0018284
28392427	676	684	assessed	T052	C1516048
28392427	688	691	CBA	T059	C0005507
28392427	694	699	ELISA	T059	C0014441
28392427	703	713	adolescent	T100	C0205653
28392427	714	721	bipolar	T048	C0005586
28392427	722	731	offspring	T099	C0680063
28392427	739	743	mean	T081	C0444504
28392427	744	747	age	T032	C0001779
28392427	752	757	years	T079	C0439234
28392427	766	769	age	T032	C0001779
28392427	776	782	gender	T032	C0079399
28392427	785	792	matched	T080	C1708943
28392427	793	800	healthy	T080	C3898900
28392427	801	809	controls	T096	C0009932
28392427	818	821	EGF	T116,T121,T125	C0242275
28392427	845	856	correlating	T080	C1707520
28392427	857	864	cluster	T081	C1704332
28392427	875	897	neurotrophic compounds	T116,T123	C0132298
28392427	908	913	S100B	T116,T123	C3711149
28392427	918	922	BDNF	T116,T121,T123	C3486709
28392427	946	955	decreased	T081	C0205216
28392427	959	964	serum	T031	C0229671
28392427	966	970	IL-7	T116,T121,T129	C0021761
28392427	972	975	SCF	T116,T123	C0143630
28392427	977	984	IGF-BP2	T116,T123	C0123257
28392427	989	994	sCD25	T116,T129,T192	C0487019
28392427	1029	1040	correlating	T080	C1707520
28392427	1041	1048	cluster	T081	C1704332
28392427	1052	1058	immune	T169	C0439662
28392427	1059	1073	growth factors	T116,T123	C0018284
28392427	1097	1106	increased	T081	C0205217
28392427	1108	1115	IGF-BP2	T116,T123	C0123257
28392427	1116	1129	significantly	T078	C0750502
28392427	1133	1138	serum	T031	C0229671
28392427	1142	1151	offspring	T099	C0680063
28392427	1162	1175	mood disorder	T048	C0525045
28392427	1177	1181	IL-7	T116,T121,T129	C0021761
28392427	1186	1189	SCF	T116,T123	C0143630
28392427	1193	1198	serum	T031	C0229671
28392427	1202	1211	offspring	T099	C0680063
28392427	1220	1231	expirienced	T041	C0596545
28392427	1234	1246	mood episode	T048	C0525045
28392427	1253	1260	pattern	T082	C0449774
28392427	1264	1266	de	T081	C0547047
28392427	1273	1282	increases	T169	C0442805
28392427	1309	1316	bipolar	T048	C0005586
28392427	1317	1326	offspring	T099	C0680063
28392427	1363	1376	mood disorder	T048	C0525045
28392427	1382	1386	time	T079	C0040223
28392427	1403	1410	IGF-BP2	T116,T123	C0123257
28392427	1411	1416	level	T080	C0441889
28392427	1433	1446	significantly	T078	C0750502
28392427	1457	1466	offspring	T099	C0680063
28392427	1486	1499	mood disorder	T048	C0525045
28392427	1501	1513	Correlations	T080	C1707520
28392427	1534	1543	published	T170	C1704324
28392427	1544	1573	immune-cellular abnormalities	T190	C4023612
28392427	1593	1603	conclusion	T078	C1707478
28392427	1617	1628	adolescents	T100	C0205653
28392427	1632	1640	familial	T169	C0241888
28392427	1641	1654	mood disorder	T048	C0525045
28392427	1655	1666	development	T169	C1527148
28392427	1667	1671	risk	T078	C0035647
28392427	1677	1690	characterized	T052	C1880022
28392427	1705	1712	pattern	T082	C0449774
28392427	1728	1737	compounds	T116,T123	C0018284
28392427	1753	1760	network	T169	C1882071
28392427	1764	1777	hematopoiesis	T042	C0018951
28392427	1779	1791	neurogenesis	T040	C0814002
28392427	1796	1808	inflammation	T046	C0021368